CHE - Chemed Corporation
| Previous Close | 477.02 |
| Open | 478.89 |
| Bid | 479.73 x 1100 |
| Ask | 481.14 x 1000 |
| Day's Range | 478.56 - 485.03 |
| 52 Week Range | 284.87 - 485.03 |
| Volume | 40,374 |
| Avg. Volume | 79,430 |
| Market Cap | 7.691B |
| Beta (5Y Monthly) | 1.09 |
| PE Ratio (TTM) | 38.12 |
| EPS (TTM) | 12.60 |
| Earnings Date | Feb 17, 2020 |
| Forward Dividend & Yield | 1.28 (0.27%) |
| Ex-Dividend Date | Nov 05, 2019 |
| 1y Target Est | 471.00 |
- Business Wire
Chemed To Report Fourth-Quarter 2019 Earnings February 18, Related Conference Call To Be Held On February 19
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2019, on Tuesday, February 18, 2020, following the close of trading on the New York Stock Exchange.
- Simply Wall St.
Is Chemed Corporation's (NYSE:CHE) ROE Of 31% Impressive?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
- Zacks
Icon PLC (ICLR) Hits Fresh High: Is There Still Room to Run?
Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- GuruFocus.com
The Competitive Advantages of Berkshire's Acquisition Business
Takeaways from Warren Buffett’s 1995 Shareholder Letter Continue reading...
- Zacks
Invest in These 5 Low Leverage Stocks Before Q4 Earnings
Companies displaying high earnings growth along with high leverage ratios should be avoided while making investment decisions. So, investors should select companies with low leverage.
- Zacks
Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think " Yes "
Chemed (CHE) could produce exceptional returns because of its solid growth attributes.
- Zacks
DVA vs. CHE: Which Stock Should Value Investors Buy Now?
DVA vs. CHE: Which Stock Is the Better Value Option?
- GuruFocus.com
The Power of Being Boring
Boring stories can often lead to exciting equity returns Continue reading...
- Simply Wall St.
Don't Sell Chemed Corporation (NYSE:CHE) Before You Read This
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll apply a basic P/E...
- Insider Monkey
Is Chemed Corporation (CHE) A Good Stock To Buy?
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition to our portfolios. The odds are not exactly stacked in investors' favor when it comes to beating the market, […]
- Simply Wall St.
A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)
In this article we are going to estimate the intrinsic value of Chemed Corporation (NYSE:CHE) by taking the expected...
- Zacks
DVA or CHE: Which Is the Better Value Stock Right Now?
DVA vs. CHE: Which Stock Is the Better Value Option?
- Zacks
Why Is Chemed (CHE) Up 7.7% Since Last Earnings Report?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GuruFocus.com
Urbem's 'Wonderful Business' Series: Chemed
It is good to be boring in the investment world Continue reading...
- Business Wire
Chemed Corporation to Present at the 2019 Credit Suisse Healthcare Conference
Chemed Corporation (CHE) today announced that it will deliver a presentation at the 28th Annual Credit Suisse Healthcare Conference on Wednesday, November 13, 2019, at approximately 10:20 a.m. (MST) at The Phoenician Hotel in Scottsdale, AZ. The presentation will be webcast live and can be accessed through the Chemed website at www.chemed.com (Investor Relations). Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
- Simply Wall St.
Have Insiders Been Selling Chemed Corporation (NYSE:CHE) Shares?
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
- Thomson Reuters StreetEvents
Edited Transcript of CHE earnings conference call or presentation 30-Oct-19 2:00pm GMT
Q3 2019 Chemed Corp Earnings Call
- Business Wire
Chemed Corporation Declares Quarterly Dividend of 32 Cents
Chemed Corporation (CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 32-cents per share on the Company’s capital stock, payable on December 2, 2019, to shareholders of record as of November 11, 2019. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
- Zacks
Chemed (CHE) Q3 Earnings Surpass Estimates, Revenues Miss
Chemed (CHE) witnesses balanced segmental growth in third-quarter 2019.
- Zacks
Chemed (CHE) Q3 Earnings Beat Estimates
Chemed (CHE) delivered earnings and revenue surprises of 4.53% and -0.89%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Chemed Reports Third-Quarter 2019 Results
Chemed Corporation , which operates VITAS Healthcare Corporation , one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation
- Zacks
Healthcare Stock Earnings Slated on Oct 29: HCA, MOH & More
Increasing demands for products and services are likely to have driven earnings for players in the healthcare industry.
- Zacks
Here's Why You Should Hold on to Chemed (CHE) Stock Right Now
Investors continue to be optimistic about Chemed's (CHE) performance.
